PMV Pharmaceuticals (PMVP) EV/Sales: History & Chart

PMV Pharmaceuticals, Inc.(PMVP)

Biotechnology · Princeton, NJ

$1.69-0.09 (-5.06%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.

Princeton, NJ

54 employees

www.pmvpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David H. Mack

View full financials

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
PMV Pharmaceuticals, Inc. (PMVP)	$90.13M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.24M	N/A	28.63x	35.79x	35.79x
ImmuCell Corporation (ICCC)vs ›	$89.84M	3.05x	2.76x	2.60x	2.86x
electroCore, Inc. (ECOR)vs ›	$89.53M	2.45x	1.93x	2.28x	2.11x
CareCloud, Inc. (CCLD)vs ›	$89.43M	1.01x	1.01x	0.60x	0.55x
Equillium, Inc. (EQ)vs ›	$91.05M	N/A	3.31x	1.36x	1.36x
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$88.97M	N/A	N/A	N/A	N/A
Biomea Fusion, Inc. (BMEA)vs ›	$91.10M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.47M	N/A	0.49x	0.49x	0.49x
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.56M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/SALES RATIO

TTM

PMV Pharmaceuticals, Inc. (PMVP)

$90.13M

N/A

Rallybio Corporation (RLYB)vs ›

$90.24M

N/A

28.63x

35.79x